EOH Holdings is now the 100% shareholder of the TCD Group of companies.


Zydus Cadila to collaborate with MMV on new anti-malaria drug

MMV (Medicines for Malaria Venture) and Zydus Cadila (Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India) have announced a collaboration to develop the investigational antimalarial compound MMV253. “Zydus Cadila and Medicines for Malaria Venture (MMV) announced a collaboration to develop the investigational anti-malarial compound, MMV674253. Zydus will lead the development of […]

October 19, 2016 0 comment
Exciting development in TB medicine for children

TB Alliance together with the Kenya Ministry of Health, UNITAID and others have released a range of new formulations of existing TB medicines tailored for children. The new medicines are easier to administer and this will hopefully increase the treatment and survival rate for children living with TB. Kenya’s Cabinet Secretary for Health, Dr. Cleopa […]

October 3, 2016 0 comment

Triclinium will for the third time participate in the annual VPM Days Conference in Hannover, Germany on 15th – 16th September 2016. VPM is Vakzine Projekt Management, a public–private partnership venture founded jointly by the German Federal Ministry of Education and Research and the Braunschweig-based Helmholtz Centre for Infection Research in 2002.  Since 2009, Triclinium […]

September 13, 2016 0 comment
New HPV Guidelines supported by American Cancer Society

The US government’s recommendation to vaccinate all pre-teens against the human papilloma virus, has received support from the American Cancer Society. According to Debbie Saslow, the cancer society’s director of cancer control intervention for HPV vaccination and women’s cancers, “HPV vaccination has the potential to prevent tens of thousands of cancers and hundreds of thousands of pre-cancers each […]

September 6, 2016 0 comment
Possible advance in AIDS vaccine design

A possible advancement in AIDS Vaccine design by researchers at the International Aids Vaccine Initiative (IAVI) and The Scripps Research Institute (TSRI) has been made. The researchers managed to create artificial nanoparticles (liposomes) which are covered with protein components (trimer spikes) which extend beyond the HIV-1’s outer membrane. The virus normally uses these protein components […]

August 1, 2016 0 comment
MMV and Novartis expand partnership

MMV and Novartis recently announced an expansion to their current partnership. Novartis will be taking the lead in the development of the antimalarial compound KAF156, which has scientific and financial support from MMV and Bill and Melinda Gates Foundation. According to Joseph Jimenez, CEO of Novartis: “With a child dying from malaria every two minutes […]

July 11, 2016 0 comment
New Memorandum of Understanding between TB Alliance and the Medicines Patent Pool to Improve Access to TB Medicines in Resource-Limited Countries

TB Alliance and the Medicines Patent Pool signed a Memorandum of Understanding in April 2016, outlining a multi-faceted plan to encourage the development of affordable new TB (tuberculosis) regimens and ensure their availability in low-and-middle income countries. TB is currently the deadliest infectious disease globally, killing one person every 20 seconds, the majority of cases […]

June 22, 2016 0 comment
Improving the effect of HIV drugs by use of the Tat vaccine

A Phase II clinical trial recently conducted in South Africa has confirmed that the therapeutic Tat vaccine can improve antiretroviral response in persons living with HIV. Triclinium was integrally involved in the trial from concept stage. For the full study report, please follow this link: http://retrovirology.biomedcentral.com/articles/10.1186/s12977-016-0261-1

June 12, 2016 0 comment
Interview: Victor Strugo – Managing Director, Triclinium Clinical Development, South Africa

The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical trials; how Triclinium has grown during a challenging decade, emerging as the largest independent home-bred CRO, winning significant preferred provider agreements and competing successfully against […]

May 30, 2016 0 comment
Benefits of receiving Influenza vaccination during pregnancy

According to new research conducted by Annette Regan from the school of pathology and laboratory medicine at the University of Western Australia in Perth, vaccinating pregnant woman against seasonal influenza could substantially reduce their risk of suffering a stillbirth when compared to mothers who do not receive the vaccine. If an expectant mother contracts influenza […]

May 9, 2016 0 comment